#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    T-cell lymphoma Squamous cell carcinoma of the oral cavity Ewing's sarcoma Arteriosclerosis Infective uveitis Subdural haematoma Small for dates baby Dedifferentiated liposarcoma Epilepsy with myoclonic-atonic seizures General anaesthesia Familial haemophagocytic lymphohistiocytosis Encephalitis autoimmune Asthma Gaucher's disease type I Immunodeficiency common variable More trials…

    Learn about Rare Diseases

    VEXAS syndrome – Diagnostics Piriformis syndrome – Treatment Marginal zone lymphoma – Life with Disease Adrenocortical carcinoma – Life with Disease Cystic fibrosis Congenital generalised lipodystrophy – Basic Information Osteosarcoma Activated PI3 kinase delta syndrome Haemophilia B without inhibitors – Life with Disease X-linked lymphoproliferative syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fampridine Chlorhexidine Gluconate Povorcitinib Aticaprant Mogamulizumab Onasemnogene Abeparvovec Bexmarilimab Soticlestat Ranitidine Irinotecan Hydrochloride Yttrium-90 Midazolam Lorlatinib Betula Verrucosa (108) Isavuconazonium Sulfate ABIRATERONE DECANOATE ATTR-01 Clavulanic Acid Sodium Iotalamate (125I) Inotuzumab Ozogamicin More therapies…

    Learn about Your Condition

    Thyroidectomy Richter's syndrome Malignant melanoma stage II Peritoneal abscess Desmoid tumour Hypocalcaemia Arthritis infective Progressive supranuclear palsy Adrenocortical carcinoma Varices oesophageal Aneurysm ruptured Neuroendocrine carcinoma Vascular calcification Thrombocytopenia Acute lymphocytic leukaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Rett syndrome

  • A Phase 3 Study of Fenfluramine Hydrochloride for Safety and Efficacy in Patients with Rett Syndrome

    Recruiting

    3 1 1
    Investigated Drugs:
    • Fenfluramine Hydrochloride
    Belgium France Germany Hungary Italy Poland +1

  • Study on the Effects of Mirtazapine for Improving Symptoms in Patients with Rett Syndrome

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Rett syndrome
    Investigated Drugs:
    • Mirtazapine
    Italy

  • Study on the Safety and Tolerability of Leriglitazone for Children with Rett Syndrome

    Not recruiting

    2 1
    Investigated Drugs:
    • Leriglitazone
    Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!